TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q2 2014 13F Holders as of 30 Jun 2014
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 1,148,777,709
- Total 13F shares
- 487,041,912
- Share change
- +11,861,493
- Total reported value
- $25,535,694,806
- Put/Call ratio
- 31%
- Price per share
- $52.42
- Number of holders
- 773
- Value change
- +$617,581,810
- Number of buys
- 322
- Number of sells
- 364
Quarterly Holders Quick Answers
What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 881624209:
Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13F
|
Company |
4.3%
|
49,273,356
|
$2,603,603,000 | — | 31 Mar 2014 | |
| Capital Research Global Investors |
13F
|
Company |
3.8%
|
43,387,300
|
$2,292,585,000 | — | 31 Mar 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.8%
|
32,364,031
|
$1,710,115,000 | — | 31 Mar 2014 | |
| FMR LLC |
13F
|
Company |
2.4%
|
27,013,912
|
$1,427,416,000 | — | 31 Mar 2014 | |
| Mondrian Investment Partners LTD |
13F
|
Company |
1.5%
|
17,630,178
|
$931,579,000 | — | 31 Mar 2014 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
14,621,995
|
$772,626,000 | — | 31 Mar 2014 | |
| Allianz Asset Management GmbH |
13F
|
Company |
1.2%
|
13,598,793
|
$718,560,000 | — | 31 Mar 2014 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
1.2%
|
13,335,767
|
$704,663,000 | — | 31 Mar 2014 | |
| PointState Capital LP |
13F
|
Company |
1.1%
|
12,736,500
|
$672,997,000 | — | 31 Mar 2014 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
0.9%
|
10,310,041
|
$544,782,000 | — | 31 Mar 2014 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.76%
|
8,764,301
|
$463,106,000 | — | 31 Mar 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.73%
|
8,341,476
|
$440,763,000 | — | 31 Mar 2014 | |
| NORGES BANK |
13F
|
Company |
0.67%
|
7,720,988
|
$407,977,000 | — | 31 Mar 2014 | |
| NWQ INVESTMENT MANAGEMENT COMPANY, LLC |
13F
|
Company |
0.55%
|
6,294,655
|
$332,610,000 | — | 31 Mar 2014 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.53%
|
6,041,102
|
$319,211,000 | — | 31 Mar 2014 | |
| HIGHFIELDS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.52%
|
6,000,000
|
$317,040,000 | — | 31 Mar 2014 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.45%
|
5,193,193
|
$274,408,000 | — | 31 Mar 2014 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.43%
|
4,994,641
|
$263,916,000 | — | 31 Mar 2014 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.43%
|
4,912,363
|
$259,569,000 | — | 31 Mar 2014 | |
| MANAGED ACCOUNT ADVISORS LLC |
13F
|
Company |
0.39%
|
4,497,580
|
$237,652,000 | — | 31 Mar 2014 | |
| RUSSELL FRANK CO/ |
13F
|
Company |
0.41%
|
4,731,779
|
$233,823,000 | — | 31 Mar 2014 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.35%
|
4,026,863
|
$212,779,441 | — | 31 Mar 2014 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.32%
|
3,728,290
|
$197,003,000 | — | 31 Mar 2014 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.31%
|
3,577,681
|
$189,045,000 | — | 31 Mar 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
3,491,072
|
$184,469,000 | — | 31 Mar 2014 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.3%
|
3,419,353
|
$180,679,000 | — | 31 Mar 2014 | |
| NORTH TIDE CAPITAL, LLC |
13F
|
Company |
0.26%
|
3,000,000
|
$158,520,000 | — | 31 Mar 2014 | |
| FIR TREE CAPITAL MANAGEMENT LP |
13F
|
Company |
0.23%
|
2,650,136
|
$140,033,000 | — | 31 Mar 2014 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
2,649,731
|
$140,012,000 | — | 31 Mar 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.23%
|
2,614,811
|
$138,161,000 | — | 31 Mar 2014 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.23%
|
2,597,092
|
$137,231,000 | — | 31 Mar 2014 | |
| Tradewinds Global Investors, LLC |
13F
|
Company |
0.22%
|
2,481,105
|
$131,102,000 | — | 31 Mar 2014 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.21%
|
2,402,458
|
$126,946,000 | — | 31 Mar 2014 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
2,278,388
|
$120,390,000 | — | 31 Mar 2014 | |
| UBS AG |
13F
|
Company |
0.19%
|
2,233,178
|
$118,002,000 | — | 31 Mar 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.19%
|
2,212,835
|
$116,927,000 | — | 31 Mar 2014 | |
| SAC Capital Advisors LP |
13F
|
Company |
0.18%
|
2,111,200
|
$111,556,000 | — | 31 Mar 2014 | |
| JANA PARTNERS LLC |
13F
|
Company |
0.18%
|
2,033,131
|
$107,431,000 | — | 31 Mar 2014 | |
| Visium Asset Management, LP |
13F
|
Company |
0.18%
|
2,012,493
|
$106,341,000 | — | 31 Mar 2014 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.17%
|
1,941,502
|
$102,589,000 | — | 31 Mar 2014 | |
| Perkins Investment Management, LLC |
13F
|
Company |
0.17%
|
1,924,830
|
$101,708,000 | — | 31 Mar 2014 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
1,954,793
|
$101,647,000 | — | 31 Mar 2014 | |
| EDGE ASSET MANAGEMENT, INC |
13F
|
Company |
0.17%
|
1,906,851
|
$100,758,000 | — | 31 Mar 2014 | |
| York Capital Management Global Advisors, LLC |
13F
|
Company |
0.16%
|
1,871,677
|
$98,899,000 | — | 31 Mar 2014 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.16%
|
1,855,917
|
$98,066,000 | — | 31 Mar 2014 | |
| BlackRock Group LTD |
13F
|
Company |
0.16%
|
1,824,107
|
$96,386,000 | — | 31 Mar 2014 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.16%
|
1,815,426
|
$95,927,000 | — | 31 Mar 2014 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
1,770,861
|
$93,573,000 | — | 31 Mar 2014 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
0.15%
|
1,760,608
|
$93,029,000 | — | 31 Mar 2014 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
1,731,842
|
$91,510,000 | — | 31 Mar 2014 |
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2014
As of 30 Jun 2014,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
773 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
487,041,912 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, Capital Research Global Investors, Invesco Ltd., Mondrian Investment Partners LTD, LAZARD ASSET MANAGEMENT LLC, WELLINGTON MANAGEMENT CO LLP, Allianz Asset Management AG, PointState Capital LP, and BARROW HANLEY MEWHINNEY & STRAUSS LLC.
This page lists
773
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2014 vs Q1 2014 Across Filers
Q1 2014 holders
765
Q2 2014 holders
773
Holder diff
8
| Investor | Q1 2014 Shares | Q2 2014 Shares | Share Diff | Share Chg % | Q1 2014 Value $ | Q2 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.